Meta-analysis: the effect of interferon on development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Authors:
- 25 March 2009
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 44 (5) , 470-475
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patientsHepatology, 2007
- Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis BGut, 2006
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2004
- Interferon-α for HBeAg-positive chronic hepatitis BJournal of Hepatology, 2003
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachJournal of Hepatology, 2001
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literatureJournal of Hepatology, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986